01647nas a2200181   4500000000100000008004100001260000900042653003100051653003000082653001100112653001300123653001700136100001700153245007800170300001000248520119300258022001401451       2012                            d  c201210aDrug Resistance, Bacterial10aDrug Therapy, Combination10aHumans10aMutation10aTuberculosis1 aMitchison DA00aPrevention of drug resistance by combined drug treatment of tuberculosis.  a87-983 a<p>Treatment with a combination of anti-tuberculosis drugs is thought to work by the first drug killing mutants resistant to the second drug, while the second drug kills those resistant to the first drug. Combined treatment has been remarkably successful in preventing the emergence of resistance during the treatment of tuberculosis. This success has led to the introduction of multi-drug treatment for leprosy, HIV infections and cancer. Its success in tuberculosis depends on a number of conditions such as the chromosomal nature of drug resistance in Mycobacterium tuberculosis and the absence of plasmids carrying resistance factors as well as the manner in which the bacterial population in tuberculosis does not come into contact with other potentially resistant bacteria. For multi-drug treatment to be effective in preventing resistance, the drugs must be sufficiently active so that each can inhibit all the bacteria in lesions. There must also be effective post-antibiotic lags in growth restarting to prevent growth between doses. Special bacterial populations that are drug tolerant or survive drug action unusually successfully are also a potential source of resistance.</p>  a0171-2004